(Q24812095)

5 July 2017

2 references

17 September 2019

25 January 2021

1 reference

Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials (English)

1 reference

5 July 2017

1 reference

17 September 2019

heterocyclic compound

1 reference

17 September 2019

1 reference

25 January 2021

1 reference

1 reference

Clive Elliott Adams

1

0 references

Kristian Wahlbeck

object named as

Kristian Wahlbeck

6

0 references

author name string

John Rathbone

2

1 reference

5 July 2017

Ben Thornley

3

1 reference

5 July 2017

Mike Clarke

4

1 reference

5 July 2017

Jo Borrill

5

1 reference

5 July 2017

A George Awad

7

1 reference

5 July 2017

language of work or name

English

0 references

publication date

17 October 2005

3 references

5 July 2017

17 September 2019

25 January 2021

3 references

5 July 2017

17 September 2019

25 January 2021

3

1 reference

5 July 2017

issue

1

0 references

page(s)

15

1 reference

Creative Commons Attribution 2.0 Generic

5 July 2017

copyright license

2 references

17 September 2019

Bias in meta-analysis detected by a simple, graphical test

25 January 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

Meta-analysis in clinical trials

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

7 April 2017

https://api.crossref.org/works/10.1186%2F1741-7015-3-15

Detecting skewness from summary information

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

The number needed to treat: a clinically useful measure of treatment effect

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

Advances in understanding and treating mental illness: implications for policy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

Psychotropic drug prescription pattern in a developing country (Nigeria). The need for an essential psychotherapeutic drug list.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

Antipsychotic drug use in the United States, 1976-1985.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

The immediate effects of chlorpromazine in newly admitted schizophrenic patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1741-7015-3-15

Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

Chlorpromazine versus placebo for schizophrenia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1274318

Chlorpromazine used with an intensive occupational therapy program; a controlled study

28 November 2018

1 reference

12 December 2020

A study of chlorpromazine: methodology and results with chronic semi-disturbed schizophrenics

1 reference

12 December 2020

The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients

1 reference

12 December 2020

Evaluation of trifluperidol in chronic schizophrenia

1 reference

12 December 2020

Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health--psychopharmacology research branch collaborative study group

1 reference

12 December 2020

Chlorpromazine and the untreated chronic schizophrenic: a long-term trial

1 reference

12 December 2020

Chlorpromazine in schizophrenic withdrawal and in the withdrawn schizophrenic

1 reference

12 December 2020

EMPLOYMENT CHARACTERISTICS OF DISCHARGED SCHIZOPHRENICS

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1741-7015-3-15

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1186/1741-7015-3-15

1 reference

Dimensions Publication ID

5 July 2017

1011717717

0 references

OpenCitations bibliographic resource ID

2921196

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

5 July 2017

1 reference